ucsf logo

Troy Cascia, AuD

He | Him | HisAudiology
Audiology Mount Zion
415-353-2101
Portrait of Troy Cascia
Portrait of Troy Cascia
ucsf logo

Troy Cascia, AuD

He | Him | HisAudiology
Audiology Mount Zion
415-353-2101

On this page

About me

Troy Cascia is a senior audiologist with expertise in diagnostic hearing assessment, hearing aid fitting, aural rehabilitation (therapies and devices to address poor hearing) and vestibular diagnostics (identifying disorders of the inner ear). He is the lead audiologist for UCSF's tinnitus program, offering diagnostic assessment, counseling and a variety of treatments. He provides services in English and Spanish.

Prior to becoming an audiologist, Cascia worked in education. Now, in his work with patients, he brings his love of learning and teaching – along with patience, compassion and attention to detail – to every encounter. His patients and their families also benefit from his years of audiological practice in a variety of health care settings.

Past president of the California Academy of Audiology, Cascia continues to promote community awareness of the audiology profession and health care for hearing.

In his spare time, Cascia enjoys traveling, hiking in the Bay Area, choral singing, and volunteering both in the local community and internationally.

Education & training

Degree

  • AUD, Pennsylvania State University of Medicine

My expertise

Locations

    My work

    What is tinnitus? The symptoms, causes and treatment for ringing in the ear

    Cascia talks about the causes of tinnitus, incuding the role of mental health.
    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.